Cargando…

Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis

Detalles Bibliográficos
Autores principales:	Bostan, Ecem, Gülseren, Duygu, Özsoy, Zehra, Bilge Ergen, Fatma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish League Against Rheumatism 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326388/ https://www.ncbi.nlm.nih.gov/pubmed/35949867 http://dx.doi.org/10.46497/ArchRheumatol.2022.8780

Ejemplares similares

Recalcitrant prurigo nodularis treated successfully with dupilumab
por: Rambhia, Pooja H., et al.
Publicado: (2019)

Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
por: Bloomstein, Joshua D., et al.
Publicado: (2021)

Dupilumab for the treatment of prurigo nodularis: A systematic review
por: Cao, Peng, et al.
Publicado: (2023)

Maintenance of response to dupilumab in prurigo nodularis: A retrospective cohort study
por: Selvaraj, Katina J., et al.
Publicado: (2023)

Treatment-resistant prurigo nodularis
por: Kolli, Sree S, et al.
Publicado: (2019)

Effective Treatment of Prurigo Nodularis with Dupilumab: A Case Report
por: Liu, Chuan, et al.
Publicado: (2022)

Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
por: Wieser, Jill K, et al.
Publicado: (2020)

Dermatoscopic Features of Prurigo Nodularis
por: Nair, Pragya A., et al.
Publicado: (2019)

Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series
por: LÖNNDAHL, Louise, et al.
Publicado: (2022)

Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report
por: Sammarra, Ilaria, et al.
Publicado: (2022)

A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis()
por: Zhang, Zhixin, et al.
Publicado: (2023)

Treatment of Refractory Prurigo Nodularis with a Monoclonal Antibody Dupilumab with Surprising Clinical Response
por: Alves, Juliana P., et al.
Publicado: (2023)

Severe pemphigoid nodularis successfully treated with dupilumab
por: Jendoubi, Fatma, et al.
Publicado: (2022)

Distinguishing truly recalcitrant prurigo nodularis from poor treatment adherence: a response to treatment-resistant prurigo nodularis [Response to letter]
por: Kowalski, Eric H, et al.
Publicado: (2019)

Effectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy
por: Liu, Taoming, et al.
Publicado: (2021)

Dupilumab-Induced Scalp Psoriasis in a Patient With Prurigo Nodularis: A Case Report
por: Al Hawsawi, Khalid, et al.
Publicado: (2023)

Prurigo nodularis after acupuncture
por: Almazan, Timothy Hermosura, et al.
Publicado: (2015)

Immunotargets and Therapy for Prurigo Nodularis
por: Labib, Angelina, et al.
Publicado: (2022)

Prevalence of Prurigo Nodularis in Poland
por: RYCZEK, Anna, et al.
Publicado: (2020)

Skin Microbiome in Prurigo Nodularis
por: Tutka, Klaudia, et al.
Publicado: (2023)

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
por: Yosipovitch, Gil, et al.
Publicado: (2023)

Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore
por: Yew, Yik Weng, et al.
Publicado: (2023)

Treatment-resistant prurigo nodularis: challenges and solutions
por: Kowalski, Eric H, et al.
Publicado: (2019)

Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer()
por: Bostan, Ecem, et al.
Publicado: (2022)

Bullous pemphigoid developed after dramatic improvement of severe prurigo nodularis()
por: Hiraiwa, Tomoko, et al.
Publicado: (2023)

Prevalence of prurigo nodularis in the United States of America: A retrospective database analysis
por: Ständer, Sonja, et al.
Publicado: (2020)

Xerosis cutis and associated co-factors in women with prurigo nodularis
por: Akarsu, Sevgi, et al.
Publicado: (2018)

The Prevalence of Psychiatric Comorbidity in Patients with Prurigo Nodularis
por: Dhawan, Lovee, et al.
Publicado: (2018)

Prurigo Nodularis after Radiotherapy: An Isoradiotopic Response?
por: Krammer, Caspar Weel, et al.
Publicado: (2018)

Prurigo nodularis in vitiligo patches: An unusual observation
por: Saleh, Karim
Publicado: (2020)

Inpatient Burden of Prurigo Nodularis in the United States
por: Whang, Katherine A., et al.
Publicado: (2019)

Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis
por: Kwon, Christina D., et al.
Publicado: (2019)

A Case of Prurigo Nodularis Treating by Acupuncture
por: Wu, Dan, et al.
Publicado: (2021)

Tofacitinib for Prurigo Nodularis: A Case Report
por: Peng, Changlan, et al.
Publicado: (2022)

Acral Prurigo Nodularis: A Case Report
por: Albinhamad, Abdulaziz, et al.
Publicado: (2022)

Patient Perspectives on Living With Severe Prurigo Nodularis
por: Rodriguez, Danielle, et al.
Publicado: (2023)

Biopsychosocial Factors Associated with Prurigo Nodularis in Endogenous Eczema
por: Oh, Choon Chiat, et al.
Publicado: (2015)

An unusual case of multibacillary leprosy mimicking prurigo nodularis
por: Noormohammadpour, Pedram, et al.
Publicado: (2020)

Abnormal Levels of Cortisol and Cortisone in Patients with Prurigo Nodularis
por: Chu, Liuxi, et al.
Publicado: (2021)

Abnormal keratin expression pattern in prurigo nodularis epidermis
por: Yang, L. L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_obirb69fq63k3fs6k6vkphtqkg